The FDA announced on September 29, 2015, that Hospira Inc. is recalling Amidate (Etomidate Injection, USP) due to failed impurity specifications. The agency stated the recall was voluntary and initiated by the firm.
How to tell if you have it
- Brand: Hospira
- Product: Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL)
- Packaging: LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter
- NDC: 0409-8060-29
- Lot Code: 34-531-DK
- Expiration Date: 10/01/2015
- Quantity: 24,100 Syringes
The hazard
The recall involves out-of-specification results for a degradation product of etomidate confirmed during stability testing. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Fresenius Kabi Epinephrine Injection Recall (May 14, 2026), Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities (September 18, 2026), and QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures (June 24, 2026).